ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,595Medicare Part D Prescriptions Filled, Including Refills

Rank: 103 out of 917

$438K Total Retail Price of All Prescriptions

Rank: 167 out of 917

365 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 365 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 365 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,398 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LEVOTHYROXINE SODIUM 338 278 1 3
POTASSIUM CHLORIDE 304 268 2 16
HYDROCODONE-ACETAMINOPHEN 298 238 S3 3 6
LISINOPRIL 274 250 4 1
HYDROCHLOROTHIAZIDE 265 244 5 9
OMEPRAZOLE 214 186 6 4
PRAVASTATIN SODIUM 201 186 7 20
LOSARTAN POTASSIUM 195 186 8 13
METFORMIN HCL 195 170 8 8
AMLODIPINE BESYLATE 192 192 10 5
FUROSEMIDE 186 176 11 7
GABAPENTIN 178 128 12 17
METOPROLOL SUCCINATE 175 171 13 18
WARFARIN SODIUM 173 158 14 10
SIMVASTATIN 165 143 15 2
SPIRONOLACTONE 165 165 15 55
ATENOLOL 151 139 17 12
ZOLPIDEM TARTRATE 148 126 18 21
PREDNISONE 131 115 19 34
ATORVASTATIN CALCIUM 121 121 20 14
METOPROLOL TARTRATE 117 104 21 11
LOVASTATIN 104 92 22 19
TRIAMTERENE-HCTZ 95 85 23 36
FAMOTIDINE 89 77 24 91
TRAMADOL HCL 87 71 25 28
FLUOXETINE HCL 79 46 26 38
SERTRALINE HCL 78 75 27 24
CYMBALTA 73 31 28 56
BENAZEPRIL HCL 73 73 28 80
VERAPAMIL ER 70 70 30 145
DIGOXIN 69 54 31 41
GLIPIZIDE 68 64 32 40
ADVAIR DISKUS 67 67 33 47
METHOTREXATE 66 43 34 183
ACETAMINOPHEN-CODEINE 64 30 S3 35 109
ALENDRONATE SODIUM 63 50 36 23
OXYBUTYNIN CHLORIDE 62 30 37 76
CITALOPRAM HBR 62 55 37 15
CARVEDILOL 61 61 39 33
DONEPEZIL HCL 59 59 40 32
DOXEPIN HCL 58 44 41 224
COLCRYS 58 58 41 255
CRESTOR 57 57 43 30
OXYCODONE HCL 55 35 S2 44 27
MELOXICAM 54 48 45 53
OXYCODONE-ACETAMINOPHEN 53 51 S2 46 46
TRAZODONE HCL 52 35 47 22
ISOSORBIDE MONONITRATE ER 52 52 47 70
AMITRIPTYLINE HCL 50 39 R 49 67
PAROXETINE HCL 50 48 49 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.